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Background: The role of JLP in cell signaling is 
not well defined. 
Results: JLP interacts with PLK1 and FOXK1 
during mitosis and ablation of JLP leads to 
increased FOXK1 protein levels. 
Conclusion: Phosphorylation of JLP by PLK1 
recruits FOXK1, whose expression and activity is 
regulated by JLP. 
Significance: Our results suggest a novel 
mechanism of regulation of FOXK1 by associating 
with JLP-PLK1 complex. 
 
ABSTRACT 
JLP (JNK associated Leucine zipper protein) is a 
scaffolding protein that interacts with various 
signaling proteins associated with coordinated 
regulation of cellular process such as endocytosis, 
motility, neurite outgrowth, cell proliferation and 
apoptosis. Here we identified Polo like kinase 1 
(PLK1) as a novel interaction partner of JLP 
through mass spectrometric approaches.  Our 
results indicate that JLP is phospho-primed by 
PLK1 on Thr 351, which is recognized by the 
PBD of PLK1 leading to phosphorylation of JLP 
at additional sites. SILAC and quantitative LC-
MS/MS analysis was performed to identify PLK1 
dependent JLP interacting proteins. Treatment of 
cells with the PLK1 kinase inhibitor BI2536 
suppressed binding of the Forkhead box protein 
K1 (FOXK1) transcriptional repressor to JLP.  JLP 
was found to interact with PLK1 and FOXK1 
during mitosis. Moreover, knockdown of PLK1 
affected the interaction between JLP and FOXK1. 
FOXK1 is a known transcriptional repressor of the 
CDK inhibitor p21/WAF1 and knockdown of JLP 
resulted in increased FOXK1 protein levels and a 
reduction of p21 transcript levels. Our results 
suggest a novel mechanism by which FOXK1 
protein levels and activity are regulated by 
associating with JLP and PLK1. 
 
INTRODUCTION 
Assembly of protein complexes that mediate 
responses to extracellular stimuli is critical to 
ensuring the execution of specific signaling 
pathways. Scaffolding proteins play key roles in 
this process by recruiting and tethering the 
proteins that convey these messages within the cell 
(1). One such well-studied scaffolding protein 
family is the family of JNK interacting proteins 
(JIP)↵. The JIP family consists of four members, 
JIP1, JIP2, JIP3 and JLP (2). Of all the members 
characterized in the JIP family, JLP is 
characterized by the presence of two leucine 
zipper (LZ) domains and a JNK binding domain 
(JBD) in its N-terminus, and a conserved C-
terminal domain all of which functions in binding 
to and forming specific cell signaling complexes 
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(3). Although JLP is ubiquitously expressed, 
previous studies have shown that the protein plays 
a role in regulating neurite outgrowth by 
interacting with SCG10 (4); activating JNK/p38 
MAPK signaling (3); regulate cell migration by 
interacting with Gα12 and Gα13 (5,6), and 
function in vesicle transport by binding to kinesin 
light chain (KLC1) and dynein microtubule motor 
proteins (7). Recent studies have identified that 
JLP and JIP3 can interact with ADP ribosylation 
factor 6 (ARF6), a small G protein that function in 
the regulating cytokinesis by transporting 
recycling endosomes to the cleavage furrow (8). 
This study showed that binding of ARF6 to JLP or 
JIP3 causes a switch in the binding to dynein as 
opposed to kinesin and that this pathway functions 
in the transport of dynein-cargo proteins out of the 
midbody during cytokinesis (8). Studies following 
this using JIP3:JLP double knockout mouse 
embryonic fibroblasts (MEF) have shown that 
these cells, when cultured in vitro, have an 
increased frequency of binucleate cells (9). In 
addition this study demonstrated the importance of 
JLP in ARF6 localization to the midbody and 
efficient cytokinesis (9). These studies uncovered 
a role for JLP in the cell cycle, which was not 
previously reported for other JIP proteins. 
 
In this study, we used a mass-spectrometry based 
approach to identify JLP-associated proteins and 
identified the mitotic kinase, Polo like kinase 1 
(PLK1), as a novel interaction partner of JLP. 
PLK1 belongs to the Polo like kinase family of 
Ser/Thr kinases and functions as a proto-
oncogene, with increased expression in various 
cancer types (10,11). The protein has an N-
terminal conserved kinase domain which functions 
in phosphorylating substrates by promoting a 
transient interaction with the protein (12,13). In 
addition, the C-terminal polo box domain (PBD), 
which recognizes and binds phospho-primed 
substrates, regulates substrate specificity and 
localization of the protein during mitosis (14-18). 
PLK1 has been characterized to phosphorylate and 
regulate the function of many proteins during 
G2/M phase ensuring smooth progression of 
mitosis (19). Here we show that JLP interacts with 
the polo box domain of PLK1 in a 
phosphorylation-dependent manner. In addition, 
we provide evidence that the interaction of JLP 
with PLK1 results in the recruitment of the 
transcription factor FOXK1 during mitosis and 
this JLP regulated function is required for down-
regulation of FOXK1 protein expression and 
activity.  
 
EXPERIMENTAL PROCEDURES 
 
Plasmids: The expression vectors encoding 
murine S-tagged full length JLP, JLP domains and 
shJLP have been described previously (3,7). 
Expression vectors for FLAG-hJLP were 
constructed by sub-cloning PCR fragments into 
the EcoRI/XhoI sites of the pCMV-Tag2B 
(Agilent technologies) vector. PLK1 expression 
vectors were constructed by sub-cloning PCR 
fragments of the PLK1 cDNA IMAGE clone into 
the pHM6-HA vector. Site directed mutagenesis of 
JLP (T351A, T334A, 2TA) and PLK1 
(H538A/K540M) was performed using 
Quickchange II XL kit according to 
manufacturer’s instructions (Agilent 
Technologies). Wild-type FLAG-FOXK1, R127A, 
H355A and the wild-type FLAG-FOXK2 plasmids 
have been described previously (20,21). The 
FOXK1 domain mutants (I, II, III) were 
constructed by sub-cloning PCR amplified 
fragments of the FLAG-FOXK1 cDNA into the 
parental vector. 
 
Antibodies and Reagents: The JLP-specific 
antibody has been described previously (3). 
Antibodies against PLK1, GAPDH, HA-tag, 
FLAG-tag, Cyclin E, S-tag, Myc-tag and p21 were 
obtained from Santa Cruz Biotechnology. 
Antibodies against FOXK1, FOXK2, BubR1 and 
T7-tag were obtained from Cell signaling 
technology and Abcam. On-Target plus Smart 
pool siPlk1, siFOXK1, siFOXK2 and siScramble 
were purchased from GE Dharmacon. Stock 
solutions of BI2536 (Selleckchem), RO3306 
(Tocris) and nocodazole (Noc) (Sigma) were 
prepared in tissue culture grade DMSO. 
 
Cell lines and Transfection: HEK293T, HeLa 
and U2OS cells were maintained in DMEM 
(Invitrogen) supplemented with 10% FBS (Sigma) 
and Penicillin/Streptomycin (Invitrogen). 
Transient transfections of exponentially growing 
cells were performed using Lipofectamine 2000 
(Invitrogen). Cells were harvested 36-48 hrs post-
transfection. For siRNA experiments, cells were 
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transfected with 30nmol of siRNA using 
Lipofectamine RNAimax (Invitrogen) and the 
cells were harvested 24-36 hrs post-transfection. 
 
Mass Spectrometry, Immunoprecipitation and 
Western blotting: To identify novel interaction 
partners through mass spectrometry, exponentially 
growing HEK293T cells were transfected with S-
tagged JLP or vector control plasmid and 
harvested 36 hrs post-transfection. The cells were 
lysed in lysis buffer (50mM HEPES, pH 7.5; 
70mM potassium acetate; 5mM magnesium 
acetate, 35mM sodium chloride, 0.2% β-D 
maltoside, supplemented with EDTA-free protease 
inhibitor tablet (Roche), 0.2mM sodium 
orthovanadate) and 5mg of protein lysate was 
incubated with S-protein agarose (69704, 
Millipore) for 2 hrs at 4 ºC. Protein complexes 
were resolved by SDS-PAGE and bands that were 
detected specifically in JLP-S sample were excised 
and subjected to microcapillary Liquid 
Chromatography-Mass spectrometry (LC-MS/MS) 
at the Taplin Mass Spectrometry Facility at 
Harvard Medical School. For interaction studies, 
cells were lysed in IP buffer (50mM HEPES, pH 
7.5; 70mM potassium acetate; 5mM magnesium 
acetate, 35mM NaCl, 0.2% TritonX-100) for 30 
mins. FLAG- and HA-tagged proteins were 
precipitated from 1mg protein lysate using FLAG-
M2 beads (Sigma) or HA-beads (Piercenet) for 2 
hrs at 4 ºC and washed well with the IP buffer. For 
immunoprecipitation using antibodies, 1mg of pre-
cleared lysate was incubated with 2 μg of antibody 
for 2 hrs at 4 ºC and the protein complexes were 
precipitated using protein-G or protein-A 
sepharose (GE healthcare) for 2 hrs. The eluted 
proteins were resolved by SDS-PAGE gel and 
subjected to Western blot analysis. Proteins were 
analyzed using the Li-Cor Odyssey imaging 
system. 
 
Proximity Ligation Assay: HeLa cells were 
grown on an 8-well chamber slide and fixed using 
4% paraformaldehyde. The cells were washed 
with PBS containing glycine and permeabilized 
using 0.1% Triton X 100 in PBS for 20 minutes. 
The cells were then blocked in blocking solution 
(PBS/10% FBS,/0.1% Triton X-100 and incubated 
with anti-JLP and anti-PLK1 antibodies diluted in 
blocking solution. The subsequent steps of the 
assay were performed according to the 
manufacturer’s instructions (DUO92101, Sigma). 
Coverslips were mounted on the slide using 
DUOLINK in situ mounting medium with DAPI. 
Images were obtained using a Carl Zeiss 
AxioImager Z1 and processed with Zen pro 2012 
imaging software (Zeiss). 
 
Kinase assays: Kinase assays were performed as 
described previously (22). Briefly, 10ng of His-
PLK1 (PV3501, Invitrogen) or GST-PLK2 
(PV4204, Invitrogen) was incubated with 2 μg of 
purified substrate, and ATP mix (10 μM cold 
ATP, 30 μCi P32γATP) for 30 mins at 30 ºC. 
Where required, kinase was pre-incubated with 
indicated concentration of inhibitor for 30 mins at 
room temperature before addition of substrate and 
ATP mix. Reactions were terminated by the 
addition of sample buffer and resolved by SDS-
PAGE. The gels were coomassie stained, dried 
and subjected to autoradiography. 
 
Cell synchronization and flow cytometry: To 
synchronize cells in the G1 phase, cells grown to 
60% confluence were washed with PBS and 
released in media containing 0.1% serum for 24 
hrs. Where indicated, the cells were treated with 
2μg/ml aphidicolin (A0781, Sigma) or 1 μM 
nocodazole overnight to synchronize cells in the S 
and G2/M phases, respectively. For double 
thymidine block, HeLa cells were treated with 
2mM thymidine for 18 hrs and released into 
complete media for 9hrs followed by a second 
round of treatment with 2mM thymidine for 18hrs. 
Cells were released into complete media and 
harvested at the indicated time points. For flow 
cytometric analysis, cells were harvested by 
trypsinization and fixed for 15 mins using 0.5% 
paraformaldehyde at room temperature. Fixed 
cells were resuspended in ice-cold 90% methanol 
added dropwise. Cells were then blocked in 2% 
BSA in PBS and stained with anti-pHis H3 
antibody (Millipore) overnight at room 
temperature. The cells were then stained for 2 
hours using an Alexa Fluor 488-conjugated 
secondary antibody prior to staining with 
propidium iodide to quantitate DNA. DNA content 
was measured using a BD-FACS Calibur (BD 
Biosciences). Cell cycle distribution was analyzed 
using Flowjo (Treestar). 
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SILAC labeling: HEK293T cells were grown for 
6-generations in Heavy and Light amino acid 
medium prior to transfection with FLAG-JLP 
plasmid. Cells were subjected to treatment as 
indicated and lysed in a Maltoside-based Lysis 
Buffer. 2 mg of cell lysate was incubated with 
FLAG-conjugated beads for 1 hour at 4 °C and 
bound proteins were eluted through treatment with 
10M Urea. The eluted protein was digested for 4 
hrs with 0.2 μg Lys-C (Wako) and then for 14hrs 
with 0.2 μg Trypsin (Promega). The samples were 
desalted using Vivapure C18 microspin columns 
and lyophilized. Mass spectrometric analysis of 
the lyophilized peptides was performed by the 
Proteome Exploration Laboratory, California 
Institute of Technology as described previously 
(23). Raw files were analyzed by MaxQuant (v. 
1.4.1.2) (24,25) in a manner similar to that 
previously described (26). Protein ratios were 
normalized to equalize bait (JLP) levels. 
 
Quantitative PCR: Total RNA was isolated from 
cell lines using the RNeasy Mini Kit (Qiagen) 
according to manufacturer’s instructions.  cDNA 
was generated from 0.5 µg of total RNA using 
Superscript III Reverse transcriptase (Invitrogen) 
according to manufacturers instructions. For 
quantitative PCR (qPCR), cDNA was mixed with 
1X Power SYBR Green PCR master mix 
(4367659, Applied Biosystems) and gene-specific 
primers. Amplification was performed using the 
ABI Step One Plus system. qPCR values were 
analyzed using the comparative Ct method to 
obtain relative gene expression levels. 
Normalization was performed using ß-actin. 
Sequences of primer pairs used for qPCR analysis 
are as follows: 
ACTB: 5’-ACCTTCTACAATGAGCTGCG-3’ 
and 5’-CCTGGATAGCAACGTACATGG-3’; 
JLP: 5’-TCACGAGAAAATCCAGCCATG-3’ 
and 5’-GAGTAACATGAGACGTGGGTG-3’; 
CDKN1A: 5’-TGTCACTGTCTTGTACCCTTG-
3’ and 5’-GGCGTTTGGAGTGGTAGAA-3’; 
FOXK1: 5’-ACATCACCAAGCATTACCCC-3’ 
and 5’-TCTATTCGCCAAAAGGACCC-3’; 
FOXK2: 5’-ACCATCAACATTCCAGACACC-3’ 
and 5’-CCACCTTGTACCCTGAAGAC-3’ 
 
 
 
 
RESULTS 
 
Polo-like kinase 1 (PLK1) is a novel interaction 
partner of JLP 
 
We undertook a mass spectrometry-based 
approach to identify novel JLP interaction 
partners. To that end, pull-down assays were 
performed from cells transfected with an 
expression vector encoding S-tagged JLP or a 
parental control plasmid. The protein complexes 
were resolved by SDS-PAGE, stained with 
coomassie blue. As shown in Fig 1A, there were a 
number of bands specifically detected in the JLP 
S-tagged precipitates. These bands were excised 
and protein constituents determined by liquid 
chromatography-mass spectrometry (LC-MS/MS) 
(Fig 1A). The predominant peptides identified in 
bands labeled 1, 2 and 4 were JLP itself, likely due 
to proteolytic cleavage of the full length protein.  
However, band 3 was made up of peptides derived 
from the mitotic Serine/Threonine kinase, Polo-
like kinase 1 (PLK1). To validate the novel JLP-
PLK1 interaction, we subjected the S-tag pull-
down precipitates to immunoblotting using a 
PLK1-specific antibody. As shown in Fig 1B, 
PLK1 was specifically precipitated by JLP but not 
in the vector control sample. To determine 
whether endogenous JLP associates with PLK1, 
HeLa cell extracts were incubated with either JLP 
or PLK1-specific antisera and the resulting 
immunoprecipitates subjected to Western blot 
analysis. The results of this study (Fig 1C) show 
that both proteins associate in reciprocal co-
immunoprecipitation assays, thereby confirming 
that endogenous JLP and PLK1 associate in cells. 
The JIP family of scaffolding proteins contains 
four members, JIP1, JIP2, JIP3 and JLP. Of these, 
JIP3 is highly homologous to JLP in its sequence 
and domain structure (3), which suggests that it 
might interact with PLK1. We therefore performed 
FLAG pull-down assays from cells over-
expressing either FLAG-tagged JIP3 or JLP and 
subjected the precipitates to Western blot analysis 
using PLK1-specific antiserum. While JLP readily 
precipitated PLK1, we failed to detect any 
associated PLK1 protein in the JIP3 sample  (Fig 
1D). 
 
To determine whether JLP interacts with PLK1 
during mitosis, HeLa cells were synchronized in 
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S-phase using a double thymidine block and 
released into the cell cycle in the presence of 
DMSO or nocodazole. Cells were then harvested 
at the indicated time points  to determine the level 
of JLP-PLK1 complexes as a function of cell cycle 
progression. The results of this study showed that 
interaction of JLP with PLK1 increases 
significantly as cells enter the mitotic phase (Fig 
2A-B). To further demonstrate that JLP and PLK1 
associate during mitosis we also performed an in 
situ proximity ligation assay (PLA), which detects 
protein-protein interactions with high degrees of 
specificity and sensitivity. HeLa cells incubated 
with JLP and PLK1 antisera that recognize the 
endogenous proteins emitted a strong PLA signal 
only in mitotic cells (Fig 2C). Background signals 
observed in interphase cells were comparable to 
the negative control (Fig 2C), suggesting that JLP 
and PLK1 proteins interact predominantly during 
mitosis. 
 
The JLP protein has several functional domains, 
including two leucine zipper domains, a JNK 
binding domain and a carboxy-terminal domain, 
which mediate protein-protein interactions (3,27). 
To map the region of JLP that interacts with 
PLK1, HEK293T cells were transfected with S-
tagged wild-type (WT) and domain mutants of 
JLP (Fig 1E). Pull down experiments showed that 
in addition to the full-length (WT) protein, PLK1 
interacts with the N-terminal domain (NTD) of 
JLP, which spans two leucine zipper domains and 
the JNK binding domain (amino acids 1-463), but 
not with any of the individual domains within the 
N-terminal region of JLP or with the C-terminus 
of the protein (domain III and CTD) (Fig 1E-F). In 
order to map the region of PLK1 that interacts 
with JLP, cells expressing HA-tagged wild-type 
and domain mutants of PLK1 (Fig 1G) were 
subjected to pull-down assays using HA-agarose 
and subsequent immunoblotting with JLP-specific 
antisera. Our results show that JLP interacts with 
the full length (WT) PLK1 protein and the domain 
mutant expressing the PLK1 polo-box domain 
(PBD aa 306-603) (Fig 1G-H), but not with the 
kinase domain (PKD aa 1-316). To confirm that 
the JLP N-terminal domain and the PLK1 Polo 
box domain interact, we performed additional 
immunoprecipitation assays using extracts derived 
from cells over-expressing a S-tagged version of 
the JLP N-terminal domain (aa 1-463) and a HA-
tagged PLK1 polo box domain mutant (aa 306-
603). As shown in Fig 1I-J, reciprocal pull-down 
experiments followed by Western blot analyses 
confirmed the association between the two 
domains. 
 
The interaction between JLP and PLK1 is 
phosphorylation dependent 
 
It has previously been established that the PBD of 
PLK1 is involved in recognizing and interacting 
with phospho-primed substrates (15). Because we 
determined that JLP binds to the PLK1 PBD (Fig 
1H), we performed experiments to determine if the 
interaction is phosphorylation dependent. JLP was 
immunoprecipitated from asynchronous cell 
lysates and the immunocomplex was treated with 
λ-phosphatase to dephosphorylate the proteins. 
Following treatment with phosphatase, the 
precipitate was washed rigorously to remove any 
unbound proteins and the level of associated PLK1 
was determined by Western blot analysis. As can 
be seen in Fig 3A, treatment with λ-phosphatase 
greatly reduced the interaction between JLP and 
PLK1, suggesting that the interaction is dependent 
on phosphorylation. We next performed additional 
interaction studies using HA-tagged wild type 
(WT) PLK1 and a PBD mutant in which two 
residues that are critical for recognizing phospho-
primed substrates, His538 and Lys540, were 
mutated to Ala and Met, respectively. Figure 3B 
shows that while WT PLK1 readily associated 
with JLP, the H538A/K540M PBD mutant (H/K) 
failed to do so. These experiments provide 
additional evidence that the JLP-PLK1 interaction 
is phosphorylation dependent. 
 
The polo box domain of PLK1 is known to initiate 
interactions by recognizing phospho-primed sites 
on its substrates with a consensus binding motif of 
Ser-[pSer/pThr]-Pro (15,16). The protein sequence 
of JLP was analyzed for the presence of this 
consensus site and a corresponding motif was 
identified at amino acid residues Thr334 and 
Thr351 within the JLP N-terminal region. To test 
whether this motif functions as a PLK1 docking 
site, these two residues were mutated to Ala either 
individually (T334A and T351A) or in 
combination (2TA) in the JLP-NTD plasmid and 
tested for their ability to bind to PLK1 in pull-
down assays. The results of this study showed that 
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while mutation of JLP at residue T334 did not 
affect binding to PLK1, mutation at Thr351 
(T351A), either alone or in the 2TA mutant, 
abolished this association (Fig 3C). Similar results 
were obtained using cells expressing FLAG-
tagged, full-length versions of the wild type or 
T351A JLP proteins (Fig 3D). In addition, the 
reciprocal experiment, whereby endogenous PLK1 
was immunoprecipitated from cells expressing 
FLAG-tagged WT and JLP-T351A mutant 
plasmids, also confirmed that wild-type JLP, but 
not the T351A mutant, associated with PLK1 (Fig 
3E). Taken together, these studies suggest that 
phospho-priming of JLP at Thr351 is required for 
its interaction with PLK1.  
 
Previous studies have shown that CDK1 serves as 
a priming kinase for PLK1 (15). There have also 
been several reports suggesting that PLK1 can also 
serve as a priming kinase which stabilizes its 
interaction with other proteins (28-30). To 
determine if these kinases play a role in priming 
JLP for PLK1 binding, HeLa cells synchronized in 
mitosis were treated with BI2536 (PLK inhibitor), 
RO3306 (CDK1 inhibitor), CX4945 (CK2 
inhibitor) or DMSO for 2 hrs. Nocodazole was 
used to synchronize cells in mitotic phase of the 
cell cycle, where PLK1 and CDK1 are expressed 
in their active state (31-33). Whole cell extracts 
were prepared and subjected to 
immunoprecipitation using a PLK1 antibody. 
Treatment with BI2536, but not the other kinase 
inhibitors, inhibited the association of JLP with 
PLK1 (Fig 3F), suggesting that PLK1 creates its 
own docking site on JLP to initiate the interaction. 
PLK1, when bound to substrates through its PBD, 
catalyzes their phosphorylation on the D/E-X-S/T-
Φ-X-D/E (X, any amino acid; Φ, a hydrophobic 
amino acid) consensus sequence (13). We 
performed in vitro kinase assays using 
recombinant His-PLK1 and GST-PLK2 to 
determine whether JLP is a substrate of one or 
both kinases. Kinase assays showed that PLK1, 
but not PLK2, can specifically phosphorylate JLP 
(Fig 3G). Furthermore, this phosphorylation is 
inhibited by BI2536 (Fig 3G). Because these 
studies indicated that JLP is a substrate of PLK1, 
we mapped the phosphorylation sites on JLP using 
a series of GST-tagged JLP deletion mutants as 
substrates in in vitro kinase assays. As shown in 
Fig 3H, JLP fragments - aa 355-559 and aa 763-
966 were phosphorylated by PLK1, suggesting 
that JLP contains multiple PLK1 phosphorylation 
sites. 
 
Interaction of JLP with PLK1 recruits FOXK1 to 
the complex 
 
Having determined that JLP interacts with and 
undergoes phosphorylation by PLK1, we next 
sought to determine if PLK1 promoted 
phosphorylation of JLP regulates the association 
of this scaffolding protein with other binding 
factors. To that end, Stable Isotope Labeling by 
Amino acids in Cell culture (SILAC) and a 
quantitative solution based LC-MS/MS interaction 
proteomics analysis (34,35) was performed in cells 
grown in media containing heavy or light isotope 
amino acids (Fig 4A). HEK293T cells over-
expressing FLAG-JLP were synchronized in the 
G2/M phase with nocodazole prior to treatment 
with 0.1 µM BI2536 or DMSO as a control. 
FLAG-tagged JLP was precipitated from the cell 
lysates and the protein complexes subjected to 
digestion using Lys-C and trypsin and processed 
for mass spectrometric analysis as described 
previously (36). To identify non-specific proteins, 
light cells expressing the parental plasmid and 
heavy cells expressing FLAG-tagged JLP plasmid 
were subjected to FLAG-pull down and further 
processed for mass spectrometric analysis. Mass 
spectral counts derived from cells expressing the 
parental plasmid were filtered out as non-specific 
interactions (data not shown). Further, a ratio-
based filter was used to identify proteins that were 
differentially pulled down in the presence or 
absence of BI2536. Using this technique we were 
able to reconfirm that PLK1 co-precipitated with 
JLP in mock-treated cells but not in BI2536 
treated sample, verifying the interaction by 
another unbiased quantitative proteomics approach 
(Table1). When we further examined the data, we 
identified two transcription factors, FOXK1 and 
FOXK2, that specifically co-precipitated with JLP 
in mock treated cells (Table 1; 22 and 5 spectra, 
respectively) but not in cells that were treated with 
PLK inhibitor, BI2536 (0 spectra for both FOXK1 
and FOXK2). To validate association of JLP with 
FOXK1 and FOXK2, we performed pull-down 
assays from cell lysates derived from 
asynchronous and G2/M-arrested HEK293T cells 
expressing FLAG-tagged FOXK1 and FOXK2 
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proteins. Immunoblotting showed that FLAG-
FOXK1 and FOXK2 interact with both JLP and 
PLK1, predominantly in cells arrested in the G2/M 
phase (Fig 4B) which express highest levels of 
PLK1. Similar results were obtained using 
nocodazole-treated cells that over-expressed Myc-
tagged JLP and FLAG-tagged FOXK1 or FOXK2 
(Fig 4C-D), which confirmed that JLP and PLK1 
interact with FOXK1 or FOXK2 in G2/M-phase 
cells. 
 
To determine if the interaction between JLP and 
FOXK1 is a cell-cycle phase specific event, HeLa 
cells over-expressing FLAG-tagged FOXK1 were 
synchronized in the G1, S or G2/M phases and 
subjected to pull-down assay using FLAG beads 
(Fig 5A). Immunoblotting showed a significant 
increase in the formation of the PLK1-JLP-
FOXK1 complex in cells synchronized in mitotic 
phase as compared to those in the G1 or S-phases. 
In addition, we performed FLAG pull down assays 
from HeLa cells that were released into cell cycle 
following a double thymidine S-phase block. Our 
results show formation of the ternary complex 
between JLP, PLK1 and FOXK1 as the cells 
progress into mitotic phase (TT8; Fig 5B).  
 
FOXK1 has a conserved DNA-binding domain 
(DBD 305-400 aa) and an N-terminal Forkhead 
association domain (FHA 123-175 aa), the latter of 
which functions in recognizing and binding 
phospho-Thr residues (37,38). In order to map the 
region(s) with which JLP and PLK1 interact, we 
over-expressed wild-type (WT) and domain 
mutants of FOXK1 (I, II, III) and subjected the 
cell lysates to pull down assays using FLAG-
beads. Our results show that while JLP strongly 
interacts with the domain mutant I containing the 
FHA domain and to a lesser extent with the DBD 
containing domain mutant II (Fig 5C-D), PLK1 
associates with the FOXK1 domain II which 
contains the DBD (Fig 5C-D). PLK1 has been 
shown to interact with and phosphorylate several 
FOX transcription factors, including FOXO1, 
FOXO3 and FOXM1 (39-41). To determine 
whether FOXM1 can also form a ternary complex 
with JLP and PLK1, we performed pull down 
assays using cell extracts derived from cells 
expressing FOXM1, PLK1 and JLP. The results of 
this study showed that PLK1, but not JLP, could 
interact with FOXM1 (Fig 5E), suggesting that the 
interaction of FOXK1 with the JLP-PLK1 
complex is highly specific. 
 
Interaction of JLP with FOXK1 is PLK1-
dependent 
 
Mass spectrometric data from the FLAG-JLP pull-
down assay showed a loss of FOXK1 in the 
BI2536-treated sample (Table 1). To further 
investigate this observation, mitotic cells over-
expressing FLAG-tagged FOXK1 were either 
mock-treated or treated with BI2536 for 2 hrs prior 
to being subjected to pull-down assays using 
FLAG beads. Western blotting of the resulting 
protein complexes showed that interaction of 
FOXK1 with both JLP and PLK1 is affected in the 
presence of the PLK1 inhibitor, BI2536 (Fig 6A) 
suggesting that BI2536 inhibits PLK1-mediated 
phosphorylation of JLP, which in turn, affects its 
association with FOXK1. We have previously 
shown that phosphorylation of JLP at Thr351 is 
required for its interaction with PLK1 (Fig 3C-E). 
To determine whether Thr351 phosphorylation 
affects its recruitment to the FOXK1-PLK1 
complex, we performed a pull-down experiment 
using cells that over-express Myc-tagged wild-
type and the JLP T351A mutant. As shown in Fig 
6B, FOXK1 associated with wild-type but not with 
the T351A mutant JLP protein. Because treatment 
with the PLK1 inhibitor BI2536 and mutation of 
JLP at Thr351 adversely affect binding of JLP to 
PLK1 and the FOXK1 transcription factor, it is 
highly likely that the formation of this ternary 
complex is phosphorylation dependent. 
  
Within the FOX family of transcription factors, 
FOXK1 and FOXK2 are the only two proteins that 
have an amino-terminal Forkhead association 
domain (FHA) in addition to the highly conserved 
winged helix DNA binding domain (WHD). 
Because the FHA domain functions in recognizing 
and binding phospho-Thr residues (42) and 
because our results show that the FHA domains 
interact with JLP (Fig 5C-D), we sought to 
determine if disrupting function of the FHA 
domain would result in changes in its ability to 
form the ternary complex. To that end, Arg127 in 
the FOXK1 FHA domain, which mediates the 
recognition and association with phospho-Thr 
residues, was mutated to Ala (R127A). As a 
control, His355 in the winged helix domain of 
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FOXK1, which is important for the protein’s 
DNA-binding function, was mutated to Ala 
(H355A) (Fig 6C). Pull-down assays from cells 
over-expressing wild type and mutant FLAG-
FOXK1 proteins showed that while the WT and 
H355A-FOXK1 proteins retained the ability to 
form a complex with PLK1 and JLP, the R127A 
mutant failed to do so (Fig 6C). This suggests that 
the FOXK1 FHA domain recognizes a 
phosphorylation site(s) on JLP when interacting 
with these proteins. Taken together, our results 
suggest that interaction of JLP with FOXK1 is 
dependent on phosphorylation of JLP by PLK1. 
To test the hypothesis that the formation of the 
ternary complex is PLK1 dependent, we 
performed interaction studies in cells where the 
expression of JLP or PLK1 was knocked down 
using shRNA or siRNA technology. HeLa cells 
expressing shJLP or scramble control (shS) were 
transfected with FLAG-tagged FOXK1, 
synchronized in mitosis using nocodazole and 
subjected to pull-down assay using FLAG beads. 
Knockdown of JLP did not affect the ability of 
PLK1 to interact with FOXK1 (Fig 6D). However, 
a parallel experiment whereby HeLa cells that 
over-express FLAG-tagged FOXK1 were 
transfected with a PLK1 siRNA or control siRNA 
for 24 hrs showed that the level of associated JLP 
with FLAG-FOXK1 was significantly reduced in 
the siPlk1 cells (Fig 6E), confirming that PLK1 is 
required for the formation of a JLP-PLK1-FOXK1 
ternary complex. 
 
Knockdown of JLP leads to an increase in FOXK1 
protein levels 
 
FOXK1 has been shown to promote myocyte 
proliferation by recruiting transcriptional co-
repressor complexes to regulate gene transcription 
(43) as well as by binding to and inhibiting 
transcription factors involved in differentiation 
(44). To determine whether JLP affects FOXK1 
activity, we knocked-down JLP expression in 
U2OS osteosarcoma cells using shRNA and 
examined the effects on FOXK1 activity. Loss of 
JLP expression (shJLP) resulted in an increase in 
and a reduction in FOXK1 and p21 protein levels, 
respectively (Fig 7A). Quantitative-PCR (qPCR) 
analysis showed that there is a significant 
reduction in p21 mRNA levels (P≤0.02) in shJLP 
cells compared to the control cells (Fig 7B). 
Furthermore, no significant differences in FOXK1 
mRNA levels were observed (Fig 7B), suggesting 
that knockdown of JLP affects FOXK1 protein 
levels. We also performed qPCR analysis in 
siControl and siFOXK1 cells, which showed a 
significant increase in p21 relative expression 
levels (P≤0.0005) upon knockdown of FOXK1 
(Fig 7C). These results are consistent with 
previous reports that demonstrated FOXK1-
mediated repression of p21 gene expression and 
increased proliferation in the C2C12 myoblast cell 
line (45). Furthermore, we performed 
immunoblotting of cell lysates derived from 
asynchronous and mitotic cells expressing control 
(shS) and shJLP. As shown in Fig 7D, knockdown 
of JLP resulted in increased levels of FOXK1 and 
a reduction in p21 levels in both cell types.  
Because our results show an increase in FOXK1 
protein levels in shJLP cells (Fig 7A,D), they 
suggest that JLP can potentially regulate the 
stability and/or degradation of FOXK1 protein in 
turn regulating the levels of its transcriptional 
targets. 
 
DISCUSSION 
 
JLP is a JNK scaffolding protein that binds to 
signaling proteins and regulates various 
developmental process such as neurite outgrowth, 
myogenesis, TGN transport and cytokinesis (2). In 
this study, using a mass spectrometric approach, 
we have identified the mitotic Ser/Thr kinase, 
PLK1 as a JLP-associated protein. Our results 
presented here show that the interaction of JLP 
with PLK1 is phosphorylation dependent (Fig 3A-
B, 7E) and that phosphorylation of JLP Thr351 is 
required for this association (Fig 3C-E, 7E). This 
interaction of PLK1 with JLP appears to be unique 
amongst the JIP family of scaffolding proteins, as 
JIP3, a member of this family which is highly 
homologous to JLP (3) fails to interact with PLK1 
(Fig 1D). Furthermore our results suggest that 
PLK1 serves as the priming kinase that 
phosphorylates JLP (Fig 3F) and uses this 
phosphorylated site for binding and 
phosphorylating additional sites in JLP  (Fig 3G-
H, 7E).   
 
Since JLP knockdown by shRNA did not result in 
an interruption of cell cycle progression (data not 
shown), we reasoned that the interaction between 
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JLP and PLK1 might result in the recruitment of 
additional protein partners to the JLP/PLK1 
complex. SILAC and quantitative LC-MS/MS 
analysis was performed to identify PLK1 
dependent JLP interacting proteins (Table 1) and 
we identified that the FOXK1 transcription factor 
interacts with the JLP/PLK1 complex in a 
phosphorylation dependent manner during mitosis. 
Our pull down assays show that PLK1 interacts 
with the FOXK1 DNA binding domain whereas 
JLP interacts with the FHA domain (Fig 5D) 
suggesting that PLK1 phosphorylates JLP and this 
phosphorylation site is recognized by FOXK1 
FHA domain. Our observation that inhibition of 
PLK1 kinase activity by BI2536 (Fig 6A) or 
knock-down by siRNA (Fig 6E), affects the 
interaction between JLP and FOXK1 highlights 
the importance of PLK1 kinase activity in the 
formation of the JLP, PLK1 and FOXK1 ternary 
complex (Fig 7E). Recent studies have shown that 
the FOX transcription factors can interact with 
different protein complexes when they are “on” or 
“off” the chromatin (46,47). This study suggests 
that the recruitment of co-regulatory proteins to 
the transcription factors determine their 
transcriptional-dependent and independent 
functions. Furthermore, FOXK1 has been shown 
to interact with and function in the nuclear 
translocation of the WNT scaffolding protein, 
Dishevelled (DVL), resulting in the activation of 
WNT/β-catenin pathway (48). Our results show 
that JLP interacts with FOXK1 predominantly 
during mitosis and knockdown of JLP results in an 
increase in FOXK1 protein levels and a reduction 
in p21 mRNA and protein levels (Fig 7A-B). This 
suggests that the increase in the FOXK1 protein 
levels could be the result of changes in the 
stability or degradation of the protein, which is 
mediated by JLP, but the detailed mechanism 
remain to be elucidated. 
 
PLK1 has been shown to phosphorylate and 
regulate the localization and transcriptional 
function of various FOX transcription factors, 
FOXM1(39), FOXO1(40), FOXO3 (41). Although 
FOXK1 is implicated as a regulator of myogenic 
proliferation (21,43-45), little is known about its 
function during mitosis. Previous studies have 
shown that CYCLIN-CDK complexes 
phosphorylate FOXK2, a protein that is highly 
homologous to FOXK1, during mitosis and that 
such phosphorylation regulates its stability and 
transcriptional function (20). Because our studies 
show the mitotic kinase, PLK1 to interact with 
FOXK1 and FOXK2, and we observed potential 
phosphorylation of FOXK1 during mitosis (data 
not shown), a similar mechanism of regulation 
might exist.    
 
In summary, we report for the first time that JLP 
can interact with a mitotic kinase, PLK1, and that 
this interaction results in recruitment of a 
transcription factor, FOXK1, to form a ternary 
complex during mitosis (Fig 7E). Although there 
are many reports suggesting a role for FOXK1 in 
proliferation and maintenance of myogenic 
progenitor cells (21,43,44), the mechanism by 
which FOXK1 functions during this process is not 
well defined. Our study describes a potentially 
novel mechanism by which FOXK1 regulates cell 
cycle dependent gene expression via association 
with a scaffolding protein, JLP. 
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FIGURE LEGENDS: 
 
Figure 1: Polo like kinase 1 (PLK1) is a novel interaction partner of JLP 
A) HEK293T cells transfected with the parental vector control (V) or a plasmid encoding S-tagged JLP 
(JLP-S) were subjected to pull-down (PD) with S-beads. Proteins were resolved by SDS-PAGE and the 
indicated bands were excised and subjected to mass spectrometric analysis. B) Immunoblot analysis of 
the pull-down samples from (A), which shows binding of endogenous PLK1 to JLP-S. C) HeLa cell 
lysates were subjected to immunoprecipitation (IP) using JLP and PLK1 specific antibodies or their 
corresponding control IgGs and subjected to Western blot analysis using the indicated antibodies. D) 
HEK293T cells over-expressing FLAG-tagged JIP3 and JLP were subjected to pull-down assays using 
FLAG beads and subjected to immunoblotting using a PLK1-specific antibody. E) Schematic 
representation of the JLP protein domains used in the pull-down assays. Amino acid numbers are 
indicated. F) Whole cell extracts isolated from HEK293T cells transfected with S-tagged wild-type JLP 
and various domain mutants were subjected to pull-down assays using S-beads. The level of associated 
PLK1 was determined using immunoblotting. G) Schematic representation of the PLK1 protein domain 
mutants used in the pull-down assays. H) Immunoblot analysis of pull-down samples from cells over-
expressing HA-PLK1 wild-type and domain mutants. *- Bands corresponding to HA-tagged PLK1 are 
indicated. I-J) HEK293T cells were transfected with expression vectors encoding HA-tagged PLK1-PBD 
and FLAG-tagged JLP-NTD and whole cell extracts were subjected to pull-down and immunoblotting 
assays. Abbreviations: V-Vector, WT-Wild type, CTD-C-terminal domain, LZ-Leucine zipper, NTD-N-
terminal domain, PKD- Protein Kinase domain, PB – Polo box, PBD – Polo-box domain. 
 
Figure 2: PLK1 interacts with JLP during mitosis 
A&B) HeLa cells were subjected to double thymidine S-phase block and released into cell cycle in the 
presence of 1μM nocodazole or DMSO as a control. Cells were harvested at the indicated time points for 
immunoprecipitation and cell cycle analysis. (A) Cell lysates were subjected to immunoprecipitation 
using JLP antibody. The immune complexes and cell lysates were analyzed by western blotting. (B) Cells 
were double stained for pHistone H3 Ser10 and propidium iodide and subjected to flow cytometry to 
determine cell cycle progression. C) PLA analysis of endogenous JLP and PLK1 in HeLa cells. Cells 
representing mitotic and interphase stages of the cell cycle are shown. Combination of antibodies used is 
indicated for each panel, IgG represents a non-specific antibody. 
 
Figure 3: Interaction of JLP with PLK1 is phosphorylation dependent   
A) JLP was immunoprecipitated from HeLa cell lysates and the resulting immunocomplexes were treated 
with 400U of λ-phosphatase (where indicated), washed to remove any unbound protein and the level of 
associated PLK1 determined by Western blot analysis. B) HEK293T cells were transfected with wild-type 
(WT) HA-PLK1 or the PLK1 H538A/K540M (H/K) mutant. HA-PLK1 was precipitated using HA-beads 
and immunoblotted with JLP-specific antiserum. C) HEK293T cells were co-transfected with plasmids 
encoding HA-tagged PLK1 Polo Box Domain (PBD) and the indicated S-tagged JLP N-terminal domain 
plasmids. Lysates were subjected to pull-down assay using HA-beads and the level of associated S-tagged 
JLP N-terminal domain was determined by immunoblotting. D-E) Lysates from HEK293T cells 
transfected with FLAG-tagged wild-type JLP and the T351A mutant were subjected to pull-down assays 
using FLAG-beads (D) or immunoprecipitation using a PLK1 antibody (E) or a control IgG antibody. The 
immunocomplexes were analyzed by western blotting using the indicated antisera. F) HeLa cells were 
were treated overnight with 0.5μM nocodazole followed by a 2hr treatment with 2 μM BI2536, 9 μM 
RO3306, 2 μM CX4945 or DMSO prior to harvesting. PLK1 was immunoprecipitated from the cell 
lysates and the level of associated JLP analyzed by western blotting. G) Purified His-tagged JLP protein 
was subjected to in vitro kinase assay using recombinant PLK1 or PLK2 in the presence of 0.1 μM 
BI2536 or DMSO. The reactions were resolved by SDS-PAGE, fixed in coomassie stain and subjected to 
autoradiography. (H) Individual regions of JLP protein (200 amino acids in length) were expressed as 
bacterial GST-fusion proteins. The purified GST-tagged JLP protein domains were subjected to in vitro 
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kinase assays using recombinant PLK1. The reactions were resolved on a SDS-PAGE and subjected to 
autoradiography. 
 
Figure 4: FOXK1 and FOXK2 interact with JLP 
A) HEK293T cells were grown in normal (light) DMEM or in media containing heavy amino acids, Arg6 
(U-13C6) and Lys8 (U-13C6, U-15N2). Cells were transfected with plasmid encoding FLAG-tagged JLP and 
treated with 1 μM nocodazole overnight and 0.1 μM BI2536 or DMSO as indicated for 1 hr prior to 
harvesting. Cell lysates were subjected to pull-down assays using FLAG-agarose. The protein complexes 
were eluted and subjected to digestion using Lys-C and trypsin. The digested peptides from 
corresponding light and heavy samples were mixed, desalted and lyophilized using a SpeedVac. The 
samples were then analyzed using an Orbitrap mass spectrometer followed by MaxQuant analysis. 
Peptides from heavy samples can be differentiated from the light samples by the change in their mass to 
charge (m/z) ratio. Potential hits were validated by immunoblotting. B) HEK293T cells were transfected 
with FLAG vector control and plasmids encoding FLAG-tagged FOXK1 or FOXK2 and treated with 1 
μM nocodazole or DMSO overnight. Cell lysates were subjected to pull-down assays using FLAG beads 
and the level of associated JLP and PLK1 analyzed by immunoblotting. C-D) HEK293T cells were 
transfected with Myc-tagged JLP and FLAG-tagged FOXK1 (C) or FLAG-FOXK2 (D). 24 hrs post-
transfection, cells were treated with nocodazole or DMSO overnight prior to harvesting. FLAG-tagged 
proteins were precipitated using FLAG-agarose and protein complexes were analyzed by western 
blotting. 
 
Figure 5: FOXK1 forms a ternary complex with JLP and PLK1 during mitosis  
A) HeLa cells transfected with FLAG-tagged FOXK1 were synchronized in the G1, S or G2/M phases as 
described in the Experimental procedures section. Cell lysates were subjected to pull-down assays using 
FLAG-agarose and the precipitates analyzed by immunoblotting. B) HeLa cells over-expressing FLAG-
FOXK1 were synchronized in S-phase by double thymidine block and released into cell cycle for the 
indicated time points. Cell lysates were subjected to FLAG pull down assay and the levels of associated 
JLP and PLK1 were determined by immunoblotting. C) Schematic representation of the FOXK1 protein 
domains used in the pull-down assays. Amino acid numbers are indicated. D) Whole cell extracts isolated 
from HEK293T cells transfected with Myc-tagged JLP, wild-type FLAG-tagged FOXK1 and the 
indicated domain mutants were subjected to pull-down assays using FLAG-beads. The levels of 
associated Myc-JLP and PLK1 were determined using immunoblotting. E) HEK293T cells over-
expressing FLAG-tagged JLP, HA-tagged PLK1 and T7-tagged FOXM1 were lysed and subjected to 
pull-down assay using HA- and FLAG-beads. Protein complexes were resolved by SDS-PAGE and 
subjected to immunoblotting using the indicated antisera. V-Vector, WT-wild-type, FHA-Forkhead 
association domain, DBD-DNA binding domain. 
 
Figure 6: FOXK1 interacts with JLP in a PLK1-dependent manner 
A) HeLa cells over-expressing FLAG-tagged FOXK1 were synchronized in mitosis and treated with 
0.1μM BI2536 or DMSO for 2 hrs. Cell lysates were subjected to pull down assay using FLAG beads and 
the levels of associated JLP and PLK1 were determined by Western blot analysis. B) Interaction of 
FLAG-FOXK1 with MYC tagged wild-type (WT) and JLP T351A in mitotic cells were analyzed by pull-
down assays using FLAG-beads and followed by immunoblotting with the indicated antibodies. C) 
Schematic representation of the FOXK1 protein. The FHA and DBD domains are indicated. HEK293T 
cells over-expressing FLAG-tagged WT, R127A and H355A FOXK1 proteins were treated with 
nocodazole overnight and subjected to pull-down assay using FLAG-beads. The resulting precipitates 
were subjected to immunoblotting using the indicated antisera. D) HeLa cells expressing shScramble 
(shS) and shJLP were transfected with a FLAG-FOXK1 expression vector, arrested in mitosis and 
subjected to pull-down assay using FLAG-beads. The levels of associated proteins were determined by 
Western blot analysis using the indicated antisera. E) siControl (siCnt) and siPlk1 cells were transfected 
with a FLAG-FOXK1 expression plasmid, treated with nocodazole for 16hrs prior to harvesting and 
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subjected to pull-down assay using FLAG beads. Associated proteins were examined by immunoblot 
analysis. 
 
Figure 7: Knockdown of JLP results in an increase in FOXK1 protein levels  
A) U2OS cells were transduced with shScramble (shS) or shJLP lentiviruses. Protein lysates from these 
cells were immunoblotted using the indicated antisera. B&C) Quantitative mRNA expression (qPCR) of 
differentially expressed genes in (B) control (shS) and shJLP cells and in (C) siControl and siFOXK1 
cells. All results were normalized to β-actin expression and graphed as average fold change (±SEM) for 
two independent experiments performed in triplicate. *P≤0.02 **P≤0.0005 D) shS and shJLP U2OS cells 
were treated overnight with 1μM nocodazole or DMSO as a control. Nocodazole treated cells were 
subjected to mitotic shake-off and cell lysates from the mitotic cells and DMSO-treated cells were 
analyzed by immunoblotting using the indicated antisera. E) Model depicting the interaction of JLP with 
PLK1 and FOXK1. PLK1 serves as the priming kinase of JLP and interacts with the N-terminal domain 
of JLP resulting in phosphorylation of JLP at additional sites. FOXK1 is recruited to bind JLP in a PLK1-
dependent manner which regulates FOXK1 protein levels and the transcript levels of its downstream 
targets. 
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TABLES: 
 
Table 1:  
 
Protein names Gene names 
Normalize
d Log2FC 
Std 
Error p-value 
DMSO 
#MS2 
BI2536 
#MS2 
Serine/threonine-protein kinase 
Polo like Kinase 1 PLK1 -2.02 0.347 5.48E-09 45 7 
Protein arginine N-
methyltransferase 5 PRMT5 0.41 0.176 1.85E-02 42 17 
Heat shock cognate 71 kDa 
protein HSPA8 0.24 0.115 3.98E-02 65 39 
RCC1 domain-containing 
protein 1 RCCD1 -0.29 0.217 1.77E-01 21 4 
C-Jun-amino-terminal kinase-
interacting protein 4 JLP 0.00 0.043 1.00E+00 1022 531 
Forkhead box protein K1 FOXK1 - - - 22 0 
Forkhead box protein K2 FOXK2 - - - 5 0 
 
Table 1: Effects of PLK1 inhibition on JLP interacting proteins in G2/M arrested cells   
HEK293T cells expressing FLAG-JLP were synchronized in G2/M phase using nocodazole and treated 
with DMSO or BI2536 for 1 hour prior to harvesting.  Cell lysates were subjected to pull down assay 
using FLAG-beads and the eluted proteins were subjected to proteomic analysis as described in materials 
and methods section. FOXK1 and FOXK2 did not have any quantifiable SILAC ratios and were only 
detected with spectra in the DMSO treated sample. 
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FIGURE 1 
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FIGURE 2 
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FIGURE 3 
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FIGURE 4 
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FIGURE 5 
 
 
  
 
 
IB: HA-PLK1 
IB: T7-FOXM1 
IB: T7-FOXM1 
PD
: H
A
 
IB: FLAG-JLP 
IB: GAPDH 
IB: HA-PLK1 
IB: FLAG-JLP 
FLAG-JLP :      +       -      + 
  HA-PLK1 :       -      +      + 
+ T7-FOXM1 
PD
:F
L
A
G
 
IB: T7-FOXM1 
IB: FLAG-JLP 
IB: HA-PLK1 
Ly
sa
te
 
C. 
IB: MYC-JLP 
IB: PLK1 
IB: GAPDH 
IB: MYC-JLP 
IB: PLK1 
IB: FLAG PD
: F
L
A
G
 
Ly
sa
te
 
FLAG-FoxK1:    V   WT   I      II    III 
MYC-JLP 
IB: JLP 
IB: PLK1 
IB: FLAG-FOXK1 
IB: JLP 
IB: PLK1 
IB: FLAG-FOXK1 
IB: GAPDH 
PD
: F
L
A
G
 
Ly
sa
te
 
G1
 
IB: CYCLIN E 
G2
/M
 
S  
 
A. B. 
1 733 
195 
400 
733 
190 
400 
WT 
I 
II 
III 
DBD FHA 
1 
IB: FLAG-FOXK1?
IB: FLAG-FOXK1?
IB: JLP?
IB: PLK1?
PD
: F
L
A
G
?
IB: JLP?
IB: PLK1?
Ly
sa
te
?
IB: CYCLIN E ?* 
TT0   TT3    TT8hrs 
Double thymidine - release 
IB: α-TUBULIN?
D. 
E. 
 at CA
LIFO
RN
IA
 IN
STITU
TE O
F TECH
N
O
LO
G
Y
 on O
ctober 19, 2015
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
                                                                              JLP forms a ternary complex with PLK1 and FOXK1 
 22 
FIGURE 6 
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FIGURE 7 
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